mirtazapine 7.5 mg

1 INDICATIONS AND USAGE Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. (1)

AvKARE

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] fatigue` `[4] off label use` `[5] diarrhoea` `[6] dyspnoea` `[7] pain` `[8] headache` `[9] vomiting` `[10] dizziness`

8 months ago

ROUND YELLOW C

8 months ago

C ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING

MIRTAZAPINE tablets, USP are supplied as: Tablet Strength Tablet Color/Shape Tablet Markings Package Configuration NDC Code 7.5 mg yellow, circular, biconvex tablet film coated tablets with “C” debossed on one side and plain on the other side Bottle / 30 count NDC 42291-494-30 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted 15° to 30°C (59° to 86°F). [see USP Controlled Room Temperature]. Protect from light and moisture.

More pills like ROUND C

Related Pills

glipizide 10 mg

american health packaging

pepto bismol fast melts winter frost flavored bismuth subsalicylate tablet chewable

the procter & gamble manufacturing company

pepto bismol fast melts fresh berry flavored bismuth subsalicylate tablet chewable

the procter & gamble manufacturing company

coldeeze cold remedy ultramelt chews zinc gluconate tablet chewable

vespyr brands inc

Chantix First Month of Therapy Pack

Physicians Total Care, Inc.

Renal Caps ASCORBIC ACID 100 mg THIAMINE MONONITRATE 1.5 mg RIBOFLAVIN 1.7 mg NIACINAMIDE 20 mg PYRIDOXINE HYDROCHLORIDE 10 mg FOLIC ACID 1 mg CYANOCOBALAMIN 6000 ug BIOTIN 150000 ug CALCIUM PANTOTHENATE 5 mg

Cypress Pharmaceutical, Inc.

Norco 10325 hydrocodone APAP Oral Tablet

Watson Pharma, Inc.

KlorCon 20 MEQ Extended Release Tablet

McKesson Contract Packaging

Guaifenesin 400 MG Oral Tablet

Sunrise Pharmaceutical Inc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site